A Multicenter, Randomized Study Evaluating the Efficacy and Safety of Canakinumab vs Placebo as Adjuvant Therapy in Subjects with Stages AJCC/UICC v. 8 II-IIIA and IIIB Completely Resected (R0) NonSmall Cell Lung C(17167)

A Multicenter, Randomized Study Evaluating the Efficacy and Safety of Canakinumab vs Placebo as Adjuvant Therapy in Subjects with Stages AJCC/UICC v. 8 II-IIIA and IIIB Completely Resected (R0) NonSmall Cell Lung C(17167)

Trial Category:
Lung
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members